BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 23/01/2020

FDA Clears Nicardipine Hydrochloride Injection for Approval

The FDA has determined that CARDENE (Nicardipine Hydrochloride) Injection, 25 mg/10 mL, was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of the generic version of the medication.

Source: Federal Register — Food and Drug AdministrationOpen original release →